BioCentury
ARTICLE | Company News

Molecular Devices, LJL BioSystems to merge

June 8, 2000 7:00 AM UTC

The companies signed a definitive merger agreement under which each LJLB share will convert into 0.30 of a share of MDCC. The deal is valued at $262.8 million based on the issuance of 4.45 million MDC...